130 related articles for article (PubMed ID: 33714521)
1. A Histologic Low-Grade Glioma with 7 Gain, 10 Loss-A Wolf in Sheep's Clothing.
Pollom EL; Soltys SG
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1137-1138. PubMed ID: 33714521
[No Abstract] [Full Text] [Related]
2. IDH1 mutation can be present in diffuse astrocytomas and giant cell glioblastomas of young children under 10 years of age.
Ferris SP; Goode B; Joseph NM; Kline CN; Samuel D; Gupta N; Bollen A; Perry A; Mueller S; Solomon DA
Acta Neuropathol; 2016 Jul; 132(1):153-5. PubMed ID: 27161253
[No Abstract] [Full Text] [Related]
3. Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation.
Orillac C; Thomas C; Dastagirzada Y; Hidalgo ET; Golfinos JG; Zagzag D; Wisoff JH; Karajannis MA; Snuderl M
Acta Neuropathol Commun; 2016 Aug; 4(1):84. PubMed ID: 27519587
[No Abstract] [Full Text] [Related]
4. T2 mapping of the peritumoral infiltration zone of glioblastoma and anaplastic astrocytoma.
Auer TA; Kern M; Fehrenbach U; Tanyldizi Y; Misch M; Wiener E
Neuroradiol J; 2021 Oct; 34(5):392-400. PubMed ID: 33573473
[TBL] [Abstract][Full Text] [Related]
5. Concurrent TERT promoter and BRAF V600E mutation in epithelioid glioblastoma and concomitant low-grade astrocytoma.
Matsumura N; Nakajima N; Yamazaki T; Nagano T; Kagoshima K; Nobusawa S; Ikota H; Yokoo H
Neuropathology; 2017 Feb; 37(1):58-63. PubMed ID: 27302309
[TBL] [Abstract][Full Text] [Related]
6. Radiomics-based prediction of multiple gene alteration incorporating mutual genetic information in glioblastoma and grade 4 astrocytoma, IDH-mutant.
Sohn B; An C; Kim D; Ahn SS; Han K; Kim SH; Kang SG; Chang JH; Lee SK
J Neurooncol; 2021 Dec; 155(3):267-276. PubMed ID: 34648115
[TBL] [Abstract][Full Text] [Related]
7. A rare case of a molecular "adult-type" diffuse astrocytoma arising in a child.
Pegolo E; Tosolini R; Nardini N; Passone E; Cogo P
Childs Nerv Syst; 2018 Feb; 34(2):191-193. PubMed ID: 29198071
[No Abstract] [Full Text] [Related]
8. In vivo Metabolic Profiles as Determined by
Wenger KJ; Hattingen E; Franz K; Steinbach J; Bähr O; Pilatus U
Clin Neuroradiol; 2019 Mar; 29(1):27-36. PubMed ID: 28983683
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and radiographic correlates of a prospectively collected molecularly profiled cohort of IDH1/2-wildtype astrocytomas.
Lin AL; Rosenblum M; Mellinghoff IK; Tabar VS; Ogilvie S; Schaff L; Yang TJ; Young RJ; Taylor BS; Jonsson P; Bale TA
Brain Pathol; 2020 May; 30(3):653-660. PubMed ID: 31984581
[TBL] [Abstract][Full Text] [Related]
10. Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma.
Zhou YX; Wang JX; Feng M; Sun CM; Sun T; Chen GL; Du ZW
J Mol Neurosci; 2012 Jul; 47(3):442-7. PubMed ID: 22113362
[TBL] [Abstract][Full Text] [Related]
11. Recent perspectives of molecular aberrations in pediatric high-grade glioma.
Li Z; Sun Q; Shi Y
Minerva Pediatr; 2020 Apr; 72(2):116-122. PubMed ID: 28643992
[TBL] [Abstract][Full Text] [Related]
12. [11C-methionine positron emission tomography in brain tumor].
Kawai N; Kagawa M; Hatakeyama T; Tamiya T; Noshiyama Y; Yamamoto Y; Miki A; Ichikawa T
No Shinkei Geka; 2008 Oct; 36(10):847-59. PubMed ID: 18975560
[No Abstract] [Full Text] [Related]
13. Dynamic FET PET Imaging of a "Butterfly" IDH-Wildtype Anaplastic Astrocytoma.
Galldiks N; Brunn A; Fink GR; Langen KJ
Clin Nucl Med; 2019 Oct; 44(10):e581-e582. PubMed ID: 31348085
[TBL] [Abstract][Full Text] [Related]
14. Secondary Glioblastoma: Molecular and Clinical Factors That Affect Outcome After Malignant Progression of a Lower Grade Tumor.
Gessler F; Zappi J; Konczalla J; Bernstock JD; Forster MT; Wagner M; Mittelbronn M; Seifert V; Senft C
World Neurosurg; 2017 Jun; 102():49-55. PubMed ID: 28263929
[TBL] [Abstract][Full Text] [Related]
15. Concomitant IDH wild-type glioblastoma and IDH1-mutant anaplastic astrocytoma in a patient with constitutional mismatch repair deficiency syndrome.
Galuppini F; Opocher E; Tabori U; Mammi I; Edwards M; Campbell B; Kelly J; Viel A; Quaia M; Rivieri F; D'Avella D; Arcella A; Giangaspero F; Fassan M; Gardiman MP
Neuropathol Appl Neurobiol; 2018 Feb; 44(2):233-239. PubMed ID: 29130549
[No Abstract] [Full Text] [Related]
16. Anaplastic Glioma: Treatment Approaches in the Era of Molecular Diagnostics.
Ruff MW; Uhm J
Curr Treat Options Oncol; 2018 Oct; 19(12):61. PubMed ID: 30361986
[TBL] [Abstract][Full Text] [Related]
17. Correlation between magnetic resonance imaging and histopathology of intracranial glioma.
Iwama T; Yamada H; Sakai N; Andoh T; Nakashima T; Hirata T; Funakoshi T
Neurol Res; 1991 Mar; 13(1):48-54. PubMed ID: 1675447
[TBL] [Abstract][Full Text] [Related]
18. Spinal Cord Astrocytoma with Isocitrate Dehydrogenase 1 Gene Mutation.
Takai K; Tanaka S; Sota T; Mukasa A; Komori T; Taniguchi M
World Neurosurg; 2017 Dec; 108():991.e13-991.e16. PubMed ID: 28866063
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical and molecular genetics study of a granular cell astrocytoma: a case report of malignant transformation to a glioblastoma.
Ishii T; Mizukawa K; Sasayama T; Sasaki H; Hayashi S; Nakamizo S; Tanaka H; Tanaka K; Hara S; Hirai C; Itoh T; Kohmura E
Neuropathology; 2013 Jun; 33(3):299-305. PubMed ID: 22994265
[TBL] [Abstract][Full Text] [Related]
20. Malignant transformation of a pleomorphic xanthoastrocytoma.
Dickerman RD
Acta Neurochir (Wien); 2006 Jan; 148(1):98. PubMed ID: 16369863
[No Abstract] [Full Text] [Related]
[Next] [New Search]
